Sequoia Fund Campaigns Against Goldman Board Member, Former Fannie CEO Jim Johnson
Found via Naked Capitalism.
As your investment manager our goal is to own shares in outstanding public companies that boast both excellent long-term performance records and ethical corporate governance standards. In the normal course of business we shouldn’t need to vote against management’s recommendations on proxy issues, because we trust management to act in our best interest.
Unfortunately, this year we are voting against James A. Johnson as he stands for re-election to the board of directors of Goldman Sachs, which we own for Sequoia Fund and separately-managed accounts. Mr. Johnson also serves on the board of Target Corp., which we own, and which should issue its proxy soon. If Mr. Johnson stands for re-election at Target, we intend to vote against him. If you vote your own shares in accounts we manage for you, we recommend you vote against James Johnson.
- Johnson & Johnson: Quality At A Reasonable Price
I mentioned in my annual dividend growth checkup that I was underweight the health care industry and was looking to increase my exposure there. I recently added shares of one health care giant, Becton, Dickinson & Company (NYSE:BDX) (Full...
- Can Johnson & Johnson Cure What Ails Your Portfolio?
Johnson & Johnson (JNJ) is well known around the dividend growth investing community with over 50 consecutive years of dividend increases. Chances are there's Johnson & Johnson products in your medicine cabinet right now and if you've...
- Recent Buy - Johnson & Johnson
Earlier this week I purchased shares of Johnson & Johnson. I was having a tough time choosing between a few stocks on my watch list including PG, IBM, PEP and UL but ultimately went with JNJ. This monster of a company will continue to grow earnings...
- Recent Buy - Johnson & Johnson (jnj)
After spending the better part of last night watching the Star Wars trailer over and over I figured I'd better get around to posting about my latest purchase! This time around I was trying to decide which stock to purchase and it came down to three...
- A Closer Look At Johnson & Johnson (jnj)
As a stock holder of many different companies I find myself checking through all kinds news and analysis on the internet. This week I thought I'd share a couple of items about the Dividend Aristocrat Johnson & Johnson. Some fellow dividend bloggers...